Fundraising Fox

Venture-Backed Startups

100,895 companies with verified investor relationships.

Atransen Pharma株式会社 がシリーズAエクステンションラウンドのクロージングを完了しました。

Atransen Pharma is a pharmaceutical company developing cancer therapies that target amino acid transporters, specifically LAT1 (large neutral amino acid transporter), which cancer cells overexpress to take up amino acids needed for growth. It develops LAT1 inhibitors intended to suppress cancer cell growth with fewer side effects.

1 investor

Atrato

Atrato Pago is a Mexican fintech providing point-of-sale credit financing that connects consumers with affiliated merchants, enabling customers to make purchases on installment plans while merchants increase sales through embedded lending.

4 investors

Atraverse Medical

1 investor

Atreca

4 investors

Atreides

Atreides builds a behavioural intelligence platform ("Insights Suite") that turns fragmented data into structured, real-time insight, plus deployable "Mission Systems" hardware and software with secure comms and edge processing for use in contested field environments. It serves operators, analysts, and decision-makers making high-consequence decisions across land, sea, air, space, and cyber domains.

1 investor

ATRenew (NYSE: RERE)

ATRenew operates a business focused on pre-owned consumer electronic devices, including recycling and redistribution, and runs charitable initiatives such as donating refurbished devices to support education. The company is based in China and engages in circular economy activities around used electronics.

1 investor

Atreo

0 investors

Atreon Orthopedics

0 investors

Atreyu

Woospin Casino is an offshore online gambling platform for Australian players, offering 1,200+ pokies from 40+ studios, live dealer tables from Evolution, and jackpot games. It operates under a Curaçao eGaming licence, quotes limits in AUD, and supports PayID, cards and cryptocurrency payments with a VIP loyalty program aimed at high-stakes players.</parameter> <parameter name="founders">[]

1 investor

Atrility

Atrility makes the AtriAmp, an FDA-cleared device that connects temporary atrial pacing wires to a bedside patient monitor to provide continuous, real-time atrial electrograms for diagnosing post-operative cardiac arrhythmias. It is used by ICU cardiologists, electrophysiologists, and nurses treating pediatric and adult patients after cardiac surgery.

1 investor

Atrin Pharmaceuticals

0 investors

Atrinsic

0 investors

Atriomx

0 investors

Atrisa

Atrisa provides an AI-powered assistant for analog circuit design, enabling engineers to create designs, debug circuits, and run simulations through natural language interaction.

1 investor

Atrium

Atrium provides an AI agent-based assistant for CEOs that acts as a chief of staff across email, messages, calendar, and CRM, surfacing daily actions and tracking relationships. It organizes a user's network with contact enrichment, meeting prep research, correspondence drafting, and a searchable memory of relationship details.

2 investors

Atrium

Atrium provides legal services to startups through a technology-enabled platform that replaces traditional hourly billing with performance-based compensation and software tools designed to increase operational transparency and efficiency.

1 investor

Atrium Insight

0 investors

Atrium Lab

1 investor

Atrium Legal Technology Services

0 investors

Atrium Sports

0 investors

Atrius

Atrius provides a cloud-based suite of applications and a unified data platform for the built environment, covering energy and sustainability tracking, indoor mapping and wayfinding, facilities and equipment health monitoring, and space and asset utilization. Its tools serve building owners, operators, and occupants managing commercial buildings.

1 investor

Atro

Atro provides a modular cybersecurity platform paired with on-demand security experts, letting small businesses deploy individual security controls (such as 2FA, endpoint protection, and pen testing), track a Security Score, and get compliance guidance for SOC 2, HIPAA, and CMMC. It serves small and mid-sized businesses, offering a free-to-start platform with paid modules and scoped expert engagements.

1 investor

Atropates Capital

0 investors

Atropos Group

0 investors